Zhang Yu, Lau Patrick, Pansky Andreas, Kassack Matthias, Hemmersbach Ruth, Tobiasch Edda
Department of Natural Sciences, Bonn-Rhine-Sieg University of Applied Sciences, 53359 Rheinbach, Germany ; Institute of Pharmacology and Medical Chemistry, University of Dusseldorf, 40225 Dusseldorf, Germany.
Institute of Aerospace Medicine, German Aerospace Center, 51147 Cologne, Germany.
Biomed Res Int. 2014;2014:413708. doi: 10.1155/2014/413708. Epub 2014 Aug 28.
Exposure to microgravity conditions causes cardiovascular deconditioning in astronauts during spaceflight. Until now, no specific drugs are available for countermeasure, since the underlying mechanism is largely unknown. Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in various vascular functions, many of which are regulated by purinergic 2 (P2) receptors. However, their function in ECs and SMCs under microgravity conditions is still unclear. In this study, primary ECs and SMCs were isolated from bovine aorta and verified with specific markers. We show for the first time that the P2 receptor expression pattern is altered in ECs and SMCs after 24 h exposure to simulated microgravity using a clinostat. However, conditioned medium compensates this change in specific P2 receptors, for example, P2X7. Notably, P2 receptors such as P2X7 might be the important players during the paracrine interaction. Additionally, ECs and SMCs secreted different cytokines under simulated microgravity, leading into a pathogenic proliferation and migration. In conclusion, our data indicate P2 receptors might be important players responding to gravity changes in ECs and SMCs. Since some artificial P2 receptor ligands are applied as drugs, it is reasonable to assume that they might be promising candidates against cardiovascular deconditioning in the future.
在太空飞行期间,宇航员暴露于微重力环境会导致心血管功能失调。到目前为止,由于其潜在机制很大程度上未知,尚无特定药物可用于应对。内皮细胞(ECs)和平滑肌细胞(SMCs)在各种血管功能中起关键作用,其中许多功能受嘌呤能2(P2)受体调节。然而,它们在微重力条件下在ECs和SMCs中的功能仍不清楚。在本研究中,从牛主动脉中分离出原代ECs和SMCs,并用特异性标记物进行验证。我们首次表明,使用回转器模拟微重力暴露24小时后,ECs和SMCs中的P2受体表达模式发生改变。然而,条件培养基可补偿特定P2受体(例如P2X7)的这种变化。值得注意的是,诸如P2X7之类的P2受体可能是旁分泌相互作用中的重要参与者。此外,在模拟微重力条件下,ECs和SMCs分泌不同的细胞因子,导致致病性增殖和迁移。总之,我们的数据表明P2受体可能是ECs和SMCs中对重力变化作出反应的重要参与者。由于一些人工P2受体配体被用作药物,因此有理由假设它们未来可能是对抗心血管功能失调的有前途的候选药物。